For OSA, the maintenance dosage will likely be 10 mg or 15 mg injected once per week. The maximum dosage of Zepbound for either of its uses is 15 mg injected once per week. »Get more information ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Kristen Gryskevich, 51, found weight to be a struggle throughout her life, but when she gave birth to her two boys in 2001 ...

Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the ...

LLY's post-market drop offers investment potential with robust R&D, capex strategies, and strong cash flow, positioning it ...

Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...

Zepbound, which has the same active ingredient, tirzepatide, is the brand name for the U.S. weight loss version, with Mounjaro sold for diabetes there. Lilly offers 5 mg, 7.5 mg and 10 mg vials of ...

Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, ...